Clinical Trials · NCT05487469
Thymosin α1 Use in Rheumatic Heart Disease Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Nanjing Medical University
- Enrollment
- 200
- Start date
- Jul 2022
- Locations
- 1 site, China
- Primary endpoint
- The highest Sequential Organ Failure Assessment (SOFA) score of 5 days after surgery